Hormone Replacement Therapy and Breast Cancer: Proceed with Caution

1. Dupont WD Page DL 1991). Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med, 151, 67–72.

2. Steinberg KK Thacker SB Stroup DF Zack MM (1991). A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA, 265, 1985–90.

3. Sillero-Arenas M Delgado-Rodriguez M Rodigues-Canteras R Bueno-Cavanillas A Galvez-Vargas R. 1992). Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol, 70, 286–294.

4. Risch HA Howe GR 1994). Menopausal hormone usage and breast cancer in Saskatchewan: a record linkage study. Am J Epidemiol, 139, 670–83.

5. Colditz GA Hankinson SE Hunter DJ Willett WC Manson JE (1995). The use of estrogens and progestins and risk of breast cancer in postmenopausal women. N Engl J Med, 332, 1589–93.

6. Petitti DB Perlman JA Sidney S. 1987). Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol, 70, 289–292.

7. Bergkvist L Adami H Persson I Bergstrom R Krusemo UB 1989). Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen replacement therapy. Am J Epidemiol, 130, 221–8.

8. Stoll BA Parbhoo S. 1988). Treatment of menopausal symptoms in breast cancer patients. Lancet, i, 1278–9.

9. Kloosterboer HJ Schoonen WGEJ Deckers GH Klijn JGM 1994). Effects of progestagens and Org OD 14 in In vitro and In Vivo Tumor Models. J Steroid Biochem Molec Biol. 49, 311–318.